Chemomab Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Chemomab Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Chemomab Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Chemomab Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Chemomab Therapeutics Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230235037A1 | Application | Method of treatment using anti-ccl24 antibody | A61K2039/505; A61K2039/545; A61K39/3955; A61K47/183; A61K47/26; A61K9/0019; A61P1/16; C07K16/24; C07K2317/24 | July 27, 2023 |
| US20230192836A1 | Application | Ccl24 inhibitors in the treatment of covid-19 | C07K16/24; C07K2317/24 | June 22, 2023 |
| EP4155317A1 | Application | Anti-eotaxin-2-antikörper zur erkennung zusätzlicher ccr3-bindender chemokine | A61K39/395; A61K2039/505; A61K2039/545; A61P37/02; A61P9/10; C07K16/24; A61P17/00; A61P37/08; A61P29/00; C07K2317/92; A61P37/00; A61P11/00; A61P3/10; A61P1/10; C07K14/47; C07K2317/565; C07K2317/76; C07K2317/31; C07K2317/24; A61P43/00; A61P13/12 | March 29, 2023 |
| EP4139352A1 | Application | Behandlungsverfahren mit anti-ccl24-antikörper | A61K2039/505; A61K2039/545; A61K39/3955; A61K47/183; A61K47/26; A61K9/0019; A61P1/16; C07K16/24; C07K2317/24 | March 01, 2023 |
| KR1020230013037A | Application | 항-ccl24 항체를 이용한 치료 방법 | A61K2039/505; A61K2039/545; A61K39/3955; A61K47/183; A61K47/26; A61K9/0019; A61P1/16; C07K16/24; C07K2317/24 | January 26, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer